Indication
Central Nervous System/Leptomeningeal Neoplasms
1 clinical trial
1 product
Clinical trial
Expanded Access Use of 131I-Omburtamab Intraventricular Radioimmunotherapy for Central Nervous System/Leptomeningeal NeoplasmsStatus:
Product
131I-omburtamab